EPAM Releases DIAL 3.0: An Evolution of Open-Source GenAI Enterprise Platform
EPAM Systems (NYSE:EPAM) has announced the release of DIAL 3.0, an enhanced version of its open-source Generative AI enterprise platform. This latest iteration represents EPAM's commitment to enabling enterprise AI adoption through a modular, open-source approach that balances innovation with governance.
The platform has evolved from an internal tool to a comprehensive framework used by global clients across various industries including financial services, healthcare, and retail. DIAL 3.0 introduces support for agentic workflows, data-native reasoning, and new approaches to handling structured and unstructured data while addressing challenges of deploying AI at scale.
Early adopter Altera Digital Health has validated the platform's effectiveness in improving operational efficiency while maintaining transparency and scalability.
EPAM Systems (NYSE:EPAM) ha annunciato il rilascio di DIAL 3.0, una versione migliorata della sua piattaforma open-source di Intelligenza Artificiale Generativa per le imprese. Questa nuova versione rappresenta l'impegno di EPAM nel favorire l'adozione dell'AI aziendale attraverso un approccio modulare e open-source che coniuga innovazione e governance.
La piattaforma si è evoluta da strumento interno a un framework completo utilizzato da clienti globali in diversi settori, tra cui servizi finanziari, sanità e retail. DIAL 3.0 introduce il supporto per flussi di lavoro agentici, ragionamento basato sui dati nativi e nuovi metodi per gestire dati strutturati e non strutturati, affrontando le sfide legate alla distribuzione dell'AI su larga scala.
Il primo utilizzatore Altera Digital Health ha confermato l'efficacia della piattaforma nel migliorare l'efficienza operativa mantenendo trasparenza e scalabilità.
EPAM Systems (NYSE:EPAM) ha anunciado el lanzamiento de DIAL 3.0, una versión mejorada de su plataforma empresarial de IA Generativa de código abierto. Esta última versión refleja el compromiso de EPAM para facilitar la adopción de IA en las empresas mediante un enfoque modular y de código abierto que equilibra innovación y gobernanza.
La plataforma ha evolucionado de ser una herramienta interna a un marco integral utilizado por clientes globales en diversos sectores, incluyendo servicios financieros, salud y comercio minorista. DIAL 3.0 introduce soporte para flujos de trabajo agentivos, razonamiento basado en datos nativos y nuevos métodos para manejar datos estructurados y no estructurados, abordando los desafíos de desplegar IA a gran escala.
El primer usuario Altera Digital Health ha validado la efectividad de la plataforma para mejorar la eficiencia operativa, manteniendo la transparencia y la escalabilidad.
EPAM Systems (NYSE:EPAM)는 오픈 소스 생성형 AI 기업 플랫폼의 향상된 버전인 DIAL 3.0을 출시했다고 발표했습니다. 이번 최신 버전은 혁신과 거버넌스의 균형을 이루는 모듈식 오픈 소스 접근 방식을 통해 기업 AI 도입을 지원하겠다는 EPAM의 의지를 보여줍니다.
이 플랫폼은 내부 도구에서 금융 서비스, 의료, 소매업 등 다양한 산업 분야의 글로벌 고객이 사용하는 종합 프레임워크로 발전했습니다. DIAL 3.0은 에이전트 워크플로우 지원, 데이터 네이티브 추론 및 구조화된 데이터와 비구조화된 데이터를 처리하는 새로운 방식을 도입하여 대규모 AI 배포의 과제를 해결합니다.
초기 도입자 Altera Digital Health는 플랫폼이 투명성과 확장성을 유지하면서 운영 효율성을 향상시키는 데 효과적임을 검증했습니다.
EPAM Systems (NYSE:EPAM) a annoncé le lancement de DIAL 3.0, une version améliorée de sa plateforme d'IA générative open-source pour les entreprises. Cette dernière version témoigne de l'engagement d'EPAM à faciliter l'adoption de l'IA en entreprise grâce à une approche modulaire et open-source qui équilibre innovation et gouvernance.
La plateforme est passée d'un outil interne à un cadre complet utilisé par des clients mondiaux dans divers secteurs, notamment les services financiers, la santé et la distribution. DIAL 3.0 introduit le support des workflows agentiques, du raisonnement natif aux données, ainsi que de nouvelles méthodes pour gérer les données structurées et non structurées, tout en relevant les défis du déploiement de l'IA à grande échelle.
Le premier utilisateur Altera Digital Health a validé l'efficacité de la plateforme pour améliorer l'efficacité opérationnelle tout en maintenant transparence et évolutivité.
EPAM Systems (NYSE:EPAM) hat die Veröffentlichung von DIAL 3.0 angekündigt, einer verbesserten Version seiner Open-Source-Generative-AI-Unternehmensplattform. Diese neueste Version zeigt EPAMs Engagement, die Einführung von Unternehmens-KI durch einen modularen, Open-Source-Ansatz zu fördern, der Innovation und Governance in Einklang bringt.
Die Plattform hat sich von einem internen Werkzeug zu einem umfassenden Framework entwickelt, das von globalen Kunden aus verschiedenen Branchen wie Finanzdienstleistungen, Gesundheitswesen und Einzelhandel genutzt wird. DIAL 3.0 führt Unterstützung für agentenbasierte Workflows, datennatives Schlussfolgern und neue Ansätze zur Verarbeitung strukturierter und unstrukturierter Daten ein und adressiert dabei die Herausforderungen bei der großflächigen Bereitstellung von KI.
Der frühe Anwender Altera Digital Health hat die Effektivität der Plattform bei der Verbesserung der Betriebseffizienz unter Beibehaltung von Transparenz und Skalierbarkeit bestätigt.
- Platform evolution from internal tool to comprehensive framework used by global enterprise clients
- Open-source approach helps clients avoid vendor lock-in while accelerating AI adoption
- Expanded capabilities including agentic workflows and data-native reasoning
- Successful implementation validated by early adopter Altera Digital Health
- None.
Insights
EPAM's DIAL 3.0 represents a strategic evolution in enterprise GenAI, balancing open-source flexibility with production-grade governance and scaling capabilities.
EPAM's release of DIAL 3.0 marks a significant evolution in their enterprise AI strategy, positioning the company advantageously in the competitive AI implementation landscape. What began as an internal tool in 2023 has matured into a comprehensive framework now used across multiple industries including financial services, healthcare, and retail.
The platform's core value proposition addresses a critical market tension: organizations' desire to adopt advanced AI capabilities while avoiding vendor lock-in. By embracing an open-source approach that supports agentic workflows and data-native reasoning, EPAM differentiates itself from closed commercial platforms while still offering enterprise-grade functionality.
Particularly noteworthy is DIAL 3.0's focus on operationalizing AI at scale in production environments—addressing the gap between experimental AI projects and business-critical deployments. The addition of new approaches for handling both structured and unstructured data significantly expands the platform's utility across diverse enterprise contexts.
EPAM's strategic positioning of DIAL reflects keen awareness of enterprise decision-makers' concerns about balancing innovation speed against governance requirements. By enabling the translation of domain knowledge into deployable logic across departments and use cases, the platform potentially reduces implementation friction—a major obstacle in enterprise AI adoption.
Altera Digital Health's continued usage since the first release provides valuable social proof, suggesting the platform delivers tangible business value beyond theoretical capabilities. This evolution from efficiency improvements to scaled AI solutions validates EPAM's continued investment in open-source innovation as a client acquisition and retention strategy.
As enterprises navigate an increasingly complex AI ecosystem marked by rapid model evolution, vendor consolidation and heightened compliance expectations, EPAM continues to invest in open source platforms as a foundational enabler. DIAL 3.0 is the latest expression of this philosophy—a platform designed to help clients accelerate value delivery while avoiding vendor lock-in, bridging commercial models with open innovation.
"Many of our clients are at a strategic crossroads, whether to build in-house capabilities or commit to commercial GenAI platforms," said Arseny Gorokh, VP of AI Enablement and Growth at EPAM. "We believe the answer is a hybrid strategy that combines the structure of platform thinking with the flexibility of open source, enabling organizations to move faster. DIAL was built to make that strategy real."
Since its initial launch in 2023, DIAL has matured from an internal enablement tool into a comprehensive framework used by global clients in financial services, healthcare, insurance, consumer packaged goods, retail and more to operationalize Generative AI. With version 3.0, EPAM introduces a platform that not only supports agentic workflows and data-native reasoning but also addresses key structural challenges of deploying AI at scale in production across business functions. It also introduces new approaches to working with structured and unstructured data using AI and fosters collaboration across entire enterprises.
"We've engineered DIAL to help organizations translate domain knowledge into deployable logic across use cases, departments and geographies," said Ilya Gorelik, VP and Head of DIALX at EPAM. "Whether you're a compliance analyst, clinical researcher or operations lead, DIAL provides the infrastructure to develop, monitor and iterate AI systems with precision."
Altera Digital Health, an early adopter of DIAL since its first release, exemplifies the value of EPAM's continued investment in open-source innovation.
"When we first started using DIAL, our goal was straightforward: improve efficiency in our operations," said Dr. Bob Taylor, Chief Product Strategist at Altera Digital Health. "What really convinced us about EPAM's approach is the continued evolution of DIAL and their clear commitment to keeping the platform open and transparent. This has given us confidence and trust as we scale our AI solutions."
To learn more about EPAM's AI-powered DIAL Open Source Platform, visit https://dialx.ai
To learn more about EPAM's advanced AI solutions and advisory capabilities, visit https://www.epam.com/services/artificial-intelligence
About EPAM Systems
Since 1993, EPAM Systems, Inc. has used its software engineering expertise to become a leading global provider of digital engineering, cloud and AI-enabled transformation services, and a leading business and experience consulting partner for global enterprises and ambitious startups. We address our clients' transformation challenges by focusing EPAM Continuum's integrated strategy, experience and technology consulting with our 30+ years of engineering execution to speed our clients' time to market and drive greater value from their innovations and digital investments.
We leverage AI and GenAI to deliver transformative solutions that accelerate our clients' digital innovation and enhance their competitive edge. Through platforms like EPAM AI/RUN™ and initiatives like DIALX Lab, we integrate advanced AI technologies into tailored business strategies, driving significant industry impact and fostering continuous innovation.
We deliver globally but engage locally with our expert teams of consultants, architects, designers and engineers, making the future real for our clients, our partners, and our people around the world. We believe the right solutions are the ones that improve people's lives and fuel competitive advantage for our clients across diverse industries. Our thinking comes to life in the experiences, products and platforms we design and bring to market.
Added to the S&P 500 and the Forbes Global 2000 in 2021 and recognized by Glassdoor and Newsweek as Most Loved Workplace, our multidisciplinary teams serve customers across six continents. We are proud to be among the top 15 companies in Information Technology Services in the Fortune 1000 and to be recognized as a leader in the IDC MarketScapes for Worldwide Experience Build Services, Worldwide Experience Design Services and Worldwide Software Engineering Services.
Learn more at www.epam.com and follow us on LinkedIn.
Forward-Looking Statements
This press release includes estimates and statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Our estimates and forward-looking statements are mainly based on our current expectations and estimates of future events and trends, which affect or may affect our business and operations. These statements may include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Those future events and trends may relate to, among other things, developments relating to the war in Ukraine and escalation of the war in the surrounding region, political and civil unrest or military action in the geographies where we conduct business and operate, difficult conditions in global capital markets, foreign exchange markets, global trade and the broader economy, the adoption and implementation of artificial intelligence technologies by EPAM and its clients, and the effect that these events may have on client demand and our revenues, operations, access to capital, and profitability. Other factors that could cause actual results to differ materially from those expressed or implied include general economic conditions, the risk factors discussed in the Company's most recent Annual Report on Form 10-K and the factors discussed in the Company's Quarterly Reports on Form 10-Q, particularly under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" and other filings with the Securities and Exchange Commission. Although we believe that these estimates and forward-looking statements are based upon reasonable assumptions, they are subject to several risks and uncertainties and are made based on information currently available to us. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/epam-releases-dial-3-0-an-evolution-of-open-source-genai-enterprise-platform-302488470.html
SOURCE EPAM Systems, Inc.
FAQ
What new features does EPAM's DIAL 3.0 platform introduce?
How has EPAM's DIAL platform evolved since its 2023 launch?
Which industries are using EPAM's DIAL platform?
What benefits does DIAL 3.0 offer for enterprise AI adoption?
How has Altera Digital Health benefited from EPAM's DIAL platform?
